Skip to main content

Advertisement

SpringerLink
Log in

Safety and Efficacy of Roux-en-Y Gastric Bypass to Treat Type 2 Diabetes Mellitus in Non-severely Obese Patients

  • New Concepts
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

The efficacy of Roux-en-Y gastric bypass (RYGB) to control type 2 diabetes mellitus (T2DM) has been demonstrated in morbidly obese patients. Surgical procedures primarily focused on T2DM control in patients with body mass index (BMI) < 35 kg/m2 have shown to effectively induce remission of T2DM. However, only few reports have evaluated the safety and efficacy of RYGB in this group of patients. The aim of this study is to assess the safety and efficacy of RYGB in TD2M patients with BMI < 35 kg/m2. All T2DM patients with BMI < 35 kg/m2 and at least 12 months of follow-up who underwent laparoscopic RYGB were included. Safety of the procedure was evaluated according to mortality, need of reoperation/conversion, and complication rates. Metabolic parameters were evaluated at baseline and 6, 12, and 24 months after surgery. Thirty patients were included. Seventeen (56.6%) were women. Age, BMI, and duration of diabetes were 48 ± 9 years, 33.7 ± 1.2 kg/m2, 4 ± 2.9 years, respectively. No mortality was observed. No conversion/reoperation was needed. Average length of stay was 3.2 ± 0.9 days. Early and late postoperative complications were observed in five (16.6%) and five (16.6%) patients, respectively. Twelve months after surgery, remission was observed in 25 of 30 patients (83.3%). After 2 years, remission was achieved in 13 of 20 patients (65%), and hemoglobin A1c decreased from 8.1 ± 1.8% to 5.9 ± 1.1% and homeostasis model assessment of insulin resistance from 5.7 ± 3.2 to 1.9 ± 0.8 after 12 months. RYGB is a safe and effective procedure to induce T2DM remission in otherwise not eligible patients for bariatric surgery. Evidence from prospective studies is needed to validate this approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195–200.

    Article  PubMed  CAS  Google Scholar 

  2. North American Association for the Study of Obesity (NAASO) and the National Heart, Lung and Blood Institute (NLHBI). The practical guide: identification, evaluation and treatment of overweight and obesity in adults. Bethesda: National Institutes of Health; 2000. NIH Publication #00-4084

  3. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg. 2004;14:1157–64.

    Article  PubMed  Google Scholar 

  4. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  PubMed  CAS  Google Scholar 

  5. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50. discussion 350–332.

    Article  PubMed  CAS  Google Scholar 

  6. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467–84. discussion 484–465.

    PubMed  Google Scholar 

  7. Wickremesekera K, Miller G, Naotunne TD, et al. Obes Surg. 2005;15:474–81.

    Article  PubMed  Google Scholar 

  8. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956–61

    Google Scholar 

  9. Cohen R, Pinheiro JS, Correa JL, et al. Laparoscopic Roux-en-Y gastric bypass for BMI < 35 kg/m(2): a tailored approach. Surg Obes Relat Dis. 2006;2:401–4. discussion 404.

    Article  PubMed  Google Scholar 

  10. Cohen RV, Schiavon CA, Pinheiro JS, et al. Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22–34 kg/m2: a report of 2 cases. Surg Obes Relat Dis. 2007;3:195–7.

    Article  PubMed  Google Scholar 

  11. DePaula AL, Macedo AL, Rassi N, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008;22:706–16.

    Article  PubMed  CAS  Google Scholar 

  12. Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945–52.

    Article  PubMed  Google Scholar 

  13. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003;26 Suppl 1:S5–S20.

    Google Scholar 

  14. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.

    Article  PubMed  CAS  Google Scholar 

  15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.

    Article  Google Scholar 

  16. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg. 2004;239:1–11.

    Article  PubMed  Google Scholar 

  17. Pacheco D, de Luis DA, Romero A, et al. The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats. Am J Surg. 2007;194:221–4.

    Article  PubMed  CAS  Google Scholar 

  18. Wang TT, Hu SY, Gao HD, et al. Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1. Ann Surg. 2008;247:968–75.

    Article  PubMed  Google Scholar 

  19. Capella JF, Capella RF. The weight reduction operation of choice: vertical banded gastroplasty or gastric bypass? Am J Surg. 1996;171:74–9.

    Article  PubMed  CAS  Google Scholar 

  20. Sugerman HJ, Londrey GL, Kellum JM, et al. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg. 1989;157:93–102.

    Article  PubMed  CAS  Google Scholar 

  21. DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235:640–5. discussion 645–647.

    Article  PubMed  Google Scholar 

  22. Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.

    Article  PubMed  CAS  Google Scholar 

  23. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y-500 patients: technique and results, with 3–60 month follow-up. Obes Surg. 2000;10:233–9.

    Article  PubMed  CAS  Google Scholar 

  24. Boza C, Salinas J, Escalona A, et al. Laparoscopic Roux-en-Y gastric bypass (LRYGB): 1500 cases and 5 year follow-up. Obes Surg. 2008;18:975.

    Google Scholar 

  25. Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242:20–8.

    Article  PubMed  Google Scholar 

  26. Escalona A, Devaud N, Boza C, et al. Gastrojejunal anastomotic stricture after Roux-en-Y gastric bypass: ambulatory management with the Savary-Gilliard dilator. Surg Endosc. 2007;21:765–8.

    Article  PubMed  CAS  Google Scholar 

  27. Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis. 2010;6:332–8.

    Article  PubMed  Google Scholar 

  28. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56. e245.

    Article  PubMed  Google Scholar 

  29. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683–93.

    Article  PubMed  Google Scholar 

  30. Hatoum IJ, Stein HK, Merrifield BF, et al. Capacity for physical activity predicts weight loss after Roux-en-Y gastric bypass. Obesity (Silver Spring). 2009;17:92–9.

    Article  Google Scholar 

  31. Perugini RA, Mason R, Czerniach DR, et al. Predictors of complication and suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass: a series of 188 patients. Arch Surg. 2003;138:541–5. discussion 545–546.

    Article  PubMed  Google Scholar 

  32. Ma Y, Pagoto SL, Olendzki BC, et al. Predictors of weight status following laparoscopic gastric bypass. Obes Surg. 2006;16:1227–31.

    Article  PubMed  Google Scholar 

  33. Dixon JB, Dixon ME, O’Brien PE. Pre-operative predictors of weight loss at 1-year after Lap-Band surgery. Obes Surg. 2001;11:200–7.

    Article  PubMed  CAS  Google Scholar 

  34. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–46.

    PubMed  CAS  Google Scholar 

  35. Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000;36:355–65.

    Article  PubMed  CAS  Google Scholar 

  36. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation. 2002;105:1727–33.

    Article  PubMed  CAS  Google Scholar 

  37. Garg A, Grundy SM. Management of dyslipidemia in NIDDM. Diabetes Care. 1990;13:153–69.

    Article  PubMed  CAS  Google Scholar 

  38. O’Brien T, Nguyen TT, Zimmerman BR. Hyperlipidemia and diabetes mellitus. Mayo Clin Proc. 1998;73:969–76.

    Article  PubMed  Google Scholar 

  39. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893–8.

    Article  PubMed  CAS  Google Scholar 

  40. Batsis JA, Romero-Corral A, Collazo-Clavell ML, et al. Effect of weight loss on predicted cardiovascular risk: change in cardiac risk after bariatric surgery. Obesity (Silver Spring). 2007;15:772–84.

    Article  Google Scholar 

  41. Rubino F, Kaplan LM, Schauer PR, et al. The Diabetes Surgery Summit Consensus Conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399–405.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

MECESUP, Faculty of Medicine, and the Department of Digestive Surgery, Pontificia Universidad Católica de Chile funded Dr. Muñoz’s scholarship.

Conflicts of Interest

None.

Author information

Authors and Affiliations

  1. Department of Digestive Surgery, Faculty of Medicine, Pontificia Universidad Católica de Chile, Marcoleta # 350, Patio Interior, Santiago, Chile

    Camilo Boza, Rodrigo Muñoz, José Salinas, Cristián Gamboa, Alex Escalona, Gustavo Pérez, Luis Ibañez & Sergio Guzmán

  2. Medical Sciences PhD Program, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

    Rodrigo Muñoz

  3. Department of Nutrition and Diabetes, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile

    Julieta Klaassen

Authors
  1. Camilo Boza
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rodrigo Muñoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. José Salinas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cristián Gamboa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Julieta Klaassen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alex Escalona
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gustavo Pérez
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Luis Ibañez
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sergio Guzmán
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Camilo Boza.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boza, C., Muñoz, R., Salinas, J. et al. Safety and Efficacy of Roux-en-Y Gastric Bypass to Treat Type 2 Diabetes Mellitus in Non-severely Obese Patients. OBES SURG 21, 1330–1336 (2011). https://doi.org/10.1007/s11695-011-0463-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-011-0463-5

Keywords

Search

Navigation